Glucagon-like Peptide-1 (GLP-1) Agonists Market Share

Statistics for the 2023 & 2024 Glucagon-like Peptide-1 (GLP-1) Agonists market share, created by Mordor Intelligence™ Industry Reports. Glucagon-like Peptide-1 (GLP-1) Agonists share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Pharmaceuticals Research Active Pharmaceutical Ingredients Research General Pharmaceuticals Research Agonists Research GLP-1 Agonists Industry Market Share

Market Share of Glucagon-like Peptide-1 (GLP-1) Agonists Industry

The GLP-1 market is consolidated, with major manufacturers, namely Eli Lilly, Sanofi, Novo Nordisk, AstraZeneca, etc., holding a presence in all regions.

Glucagon-like Peptide-1 (GLP-1) Agonists Market Leaders

  1. AstraZeneca

  2. Eli Lilly and Company

  3. Sanofi

  4. Novo Nordisk A/S

  5. Pfizer Inc.

*Disclaimer: Major Players sorted in no particular order

Glucagon-like Peptide-1 (GLP-1) Agonists Market Concentration

GLP-1 Agonists Market Report Snapshots

GLP-1 Agonist Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)